HU0302029D0 - Amorphous form of an anticoagulant agent - Google Patents
Amorphous form of an anticoagulant agentInfo
- Publication number
- HU0302029D0 HU0302029D0 HU0302029A HUP0302029A HU0302029D0 HU 0302029 D0 HU0302029 D0 HU 0302029D0 HU 0302029 A HU0302029 A HU 0302029A HU P0302029 A HUP0302029 A HU P0302029A HU 0302029 D0 HU0302029 D0 HU 0302029D0
- Authority
- HU
- Hungary
- Prior art keywords
- amorphous form
- anticoagulant agent
- anticoagulant
- agent
- amorphous
- Prior art date
Links
- 239000003146 anticoagulant agent Substances 0.000 title 1
- 229940127090 anticoagulant agent Drugs 0.000 title 1
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0302029A HU0302029D0 (en) | 2003-07-02 | 2003-07-02 | Amorphous form of an anticoagulant agent |
CNB2004800184226A CN100404539C (en) | 2003-07-02 | 2004-06-30 | Process for preparing amorphous form of a medicament - blood platelet coagulation inhibitor |
PCT/HU2004/000069 WO2005003138A2 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
EA200600137A EA200600137A1 (en) | 2003-07-02 | 2004-06-30 | Method for producing amorphous form of an inhibitor of platelet aggregation |
US10/562,978 US7396931B2 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
JP2006516496A JP2007516166A (en) | 2003-07-02 | 2004-06-30 | Preparation of amorphous form of platelet aggregation inhibitor |
EP04743728A EP1648903A2 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
PL378711A PL378711A1 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
SK5011-2006A SK50112006A3 (en) | 2003-07-02 | 2004-06-30 | Process for preparation of amorphous form of platelet aggregation inhibitor drug |
KR1020067000040A KR20060026121A (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
CA002530446A CA2530446A1 (en) | 2003-07-02 | 2004-06-30 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
CZ20060060A CZ200660A3 (en) | 2003-07-02 | 2006-01-27 | Process for preparing amorphous form of a medicament - blood platelet coagulation inhibitor |
BG109428A BG109428A (en) | 2003-07-02 | 2006-02-02 | Process for the preparation of amorphous form of a platelet aggregation inhibitor drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0302029A HU0302029D0 (en) | 2003-07-02 | 2003-07-02 | Amorphous form of an anticoagulant agent |
Publications (1)
Publication Number | Publication Date |
---|---|
HU0302029D0 true HU0302029D0 (en) | 2003-09-29 |
Family
ID=89981478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0302029A HU0302029D0 (en) | 2003-07-02 | 2003-07-02 | Amorphous form of an anticoagulant agent |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN100404539C (en) |
HU (1) | HU0302029D0 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2316650T3 (en) * | 2001-12-18 | 2009-04-16 | Teva Pharmaceutical Industries Ltd. | CLOPIDOGREL HYDROGENOSULPHATE POLYMORPHES. |
-
2003
- 2003-07-02 HU HU0302029A patent/HU0302029D0/en unknown
-
2004
- 2004-06-30 CN CNB2004800184226A patent/CN100404539C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN100404539C (en) | 2008-07-23 |
CN1812994A (en) | 2006-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG23766A (en) | Confortable diaper | |
ZA200508997B (en) | Preparation of an osteoinductive agent | |
GB0325192D0 (en) | Method of use | |
EP1669046A4 (en) | Absorbent article | |
ZA200605348B (en) | Solid forms of anti-EGFR-antibodies | |
EP1745573A4 (en) | Methods of manufacture of 2 -deoxy- beta-l-nucleosides | |
HK1096839A1 (en) | Conforming earplug | |
EP1676582A4 (en) | Anti-coronavirus agent | |
SI1587542T1 (en) | Use of anti-cd100 antibodies | |
GB0326439D0 (en) | Methods | |
TWI317632B (en) | Absorbent article | |
SI1547555T1 (en) | Absorbent article | |
GB0305989D0 (en) | Agent | |
HK1092846A1 (en) | Multifunctional textile-pretreating agent | |
GB0318257D0 (en) | Nucleating agent | |
EP1709976A4 (en) | Emt- inducing agents | |
AU2003264519A1 (en) | Deodorant agent | |
HU0302029D0 (en) | Amorphous form of an anticoagulant agent | |
PL377902A1 (en) | Novel use of phosphor-nitrogen-metal complex | |
PL376675A1 (en) | Absorbent article including an absorbent structure | |
GB2417690B (en) | Condom | |
PL361719A1 (en) | Tampon | |
GB0307076D0 (en) | Methods | |
GB0323793D0 (en) | Methods | |
GB0323744D0 (en) | Nappy |